BioMarker Strategies
Rockville, US · Maryland LLC
Founders & leadership
JP
Jerry ParrottExecutive
Board
GM
Glenn MillerBoard director
SA
Scott AlloccoBoard director
KK
Katarzyna KusmierzBoard director
DC
Douglas ClarkBoard director
JD
Jack DavisBoard director
Reported raises · per SEC filings
Form D private placements$525K disclosed across 1 of 2 rounds · 2015–2016
▶$525KraisedSep 2016 · 2 investors · BiotechnologyRule 506(b)
▶$525KraisedSep 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katarzyna KusmierzDirector
- Jerry ParrottExecutive Officer, Director
- Jack DavisDirector
- Scott AlloccoDirector
- Glenn MillerDirector
- Douglas ClarkDirector
- Amount sold
- $525K
- Minimum investment
- $25K
- First sale
- Aug 2016
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2015 · 2 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glenn MillerDirector
- Jerry ParrottExecutive Officer, Director
- Scott AlloccoDirector
- Katarzyna KusmierzDirector
- Douglas ClarkDirector
- Jack DavisDirector
- Minimum investment
- $25K
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Cartography Biosciences3 shared keywordsCartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
Bio Strategy3 shared keywordsDistributor of scientific instrumentation and laboratory consumables serving food and beverage manufacturers, production, and materials science customers across Australia and New Zealand. Offers equipment and services for physical and chemical characterisation, life science, sample preparation, and general lab needs.
Companies competing with BioMarker Strategies for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $299.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $192.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $254.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has BioMarker Strategies raised?
- BioMarker Strategies has disclosed $525K raised across 1 of its 2 known rounds.
- Where is BioMarker Strategies headquartered?
- BioMarker Strategies is headquartered in Rockville, US.